Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7845
Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico City
BERENICE ZAVALA BARRIOS
JESÚS CARLOS BRIONES GARDUÑO
GUADALUPE M.L. GUERRERO AVENDAÑO
Eduardo Ferat
Patricia Miranda Cruz
Arturo Cérbulo-Vázquez
Lourdes Arriaga_Pizano
MARIA TERESA GARCIA DE LA ROSA
Jessica Lakshmi Prieto-Chávez
Vanessa Rivero-Arredondo
RUTH MADERA
ENRIQUE SALAZAR RÍOS
Roberto Carlos De Lira Barraza
Abel Humberto Villanueva Compean
CONSTANTINO LOPEZ MACIAS
guillermo flores padilla
Acceso Abierto
Atribución-SinDerivadas
https://doi.org/10.1101/2020.07.14.20153585
On January 30th, 2020, the WHO declared the outbreak of COVID19, a disease due to the new coronavirus called SARS-CoV-2. Certain comorbidities, symptoms and signs are characteristic of COVID19 in the general population and in pregnant women. However, pregnant women are considered as a high-risk group for COVID19. To know about the frequency of comorbidities, signs and symptoms, the presence of lymphopenia, antibodies response to SARS-CoV2 and cytokine and chemokine serum concentration, six pregnant women with COVID19 were studied at the moment of admission. The lower concentration of CCL17 was detected in the Pregnant COVID19 group, similar concentration of IL-6 was also detected in non-pregnant and pregnant COVID19 patients. Our result show that pregnant and non-pregnant women with COVID19 has similar cytokine profile.
Medrxiv
17-07-2020
Preimpreso
medrxiv.org/
Inglés
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos: